AI accelerates search for motor neurone disease treatments by repurposing existing drugs
By
Zoe Kleinman, Philippa Wain
A weekday bagel. Dependable, satisfying, no fuss.
Summary
Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, the approach aims to bypass the lengthy 10+ year timeline typically required for new drug development. The team, led by Prof Chandran, believes this method could deliver affordable and effective treatments for neurological conditions much sooner. The work builds on previous efforts using AI to uncover solutions from large medical datasets.
Key quotes
· 3 pulledBecause the drugs have already been developed and approved, redeploying them can be more straightforward than starting from scratch with new formulas.
Discovering new drugs and getting them to market can take a long time - more than 10 years, according to some estimates.
Prof Chandran and his team believe their work means affordable, effective drugs for neurological conditions could come much sooner.
You might also wanna read

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse

Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep
Personal Mission to Accelerate Brain Tumor Research Using AI Scientists
A personal narrative about a man whose girlfriend was diagnosed with a brain tumor, leading him to launch an experiment using AI-Scientists
